Zions Bancorporation’s NEVRO CORP. NVRO Stock Holding History

Zions Bancorporation’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-44	Closed	-$1.74K	–	1053
2022 Q4	$1.74K	Buy	+44	New	+$1.83K	﹤0.01%	963

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zions Bancorporation's NVRO Position: Q1 2023 in Review

Zions Bancorporation sold out of NEVRO CORP. (NVRO) in Q1 2023, closing a stake of 44 shares — an estimated $1.74K sold.

Zions Bancorporation first reported a position in NVRO in Q4 2022 and held it in 1 quarter. The position peaked at $1.74K in Q4 2022. 158 funds tracked by Wall St. Rank hold NVRO as of Q1 2023.

Zions Bancorporation reported no remaining NEVRO CORP. position as of Q1 2023 after selling out during the quarter.
Zions Bancorporation sold 44 NEVRO CORP. shares in Q1 2023, an estimated $1.74K.
Zions Bancorporation first reported a position in NEVRO CORP. in Q4 2022 and held it in 1 quarter.
Zions Bancorporation's NEVRO CORP. position peaked at $1.74K in Q4 2022.
158 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2023.

Based on Zions Bancorporation's 13F filing for Q1 2023, filed 10 May 2023.